MARCELO DER TOROSSIAN Torres lifted the clear plastic cover off of a petri dish one morning last June. The dish, still warm from its sleepover in the incubator, smelled of rancid broth. Inside it sat a rubbery bed of amber-colored agar, and on that bed lay neat rows of pinpricks—dozens of colonies of drug-resistant bacteria sampled from the skin of a lab mouse.
Torres counted each pinprick softly to himself, then did some quick calculations. Untreated for the infection, the samples taken from an abscess on the mouse had yielded billions of superbugs, or antibiotic-resistant bacteria. But to his surprise, some of the other rows on the petri dish seemed empty. These were the ones corresponding to samples from mice that received an experimental treatment—a novel antibiotic.
RGPD et cybersécurité : comment rester conforme en 2025 Depuis sa mise en application en…
VPN : un outil indispensable pour protéger vos données Le VPN, ou « Virtual Private…
Cybersécurité et PME : les risques à ne pas sous-estimer On pense souvent que seules…
Comment reconnaître une attaque de phishing et s’en protéger Le phishing ou « hameçonnage »…
Qu’est-ce que la cybersécurité ? Définition, enjeux et bonnes pratiques en 2025 La cybersécurité est…
Cybersécurité : les établissements de santé renforcent leur défense grâce aux exercices de crise Face…
This website uses cookies.